Galmarini, C. M., Clarke, M. L., Jordheim, L., Santos, C. L., Cros, E., Mackey, J. R., & Dumontet, C. (2004). Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene. BioMed Central.
Chicago Style CitationGalmarini, Carlos María, Marilyn L. Clarke, Lars Jordheim, Cheryl L. Santos, Emeline Cros, John R. Mackey, and Charles Dumontet. Resistance to Gemcitabine in a Human Follicular Lymphoma Cell Line Is Due to Partial Deletion of the Deoxycytidine Kinase Gene. BioMed Central, 2004.
MLA CitationGalmarini, Carlos María, et al. Resistance to Gemcitabine in a Human Follicular Lymphoma Cell Line Is Due to Partial Deletion of the Deoxycytidine Kinase Gene. BioMed Central, 2004.
Warning: These citations may not always be 100% accurate.